If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Reference standard · Research use only
Body Protection Compound 15-mer
Price, MOQ and lead time come in your written quote — usually within 24 hours. No account needed.
Compound facts
| Name | BPC-157 |
|---|---|
| CAS number | 137525-51-0 |
| PubChem CID | 9941957 |
| Molecular formula | C62H98N16O22 |
| Molecular weight | 1419.55 g/mol |
| Sequence | GEPPPGKPADDAGLV |
| Appearance | White to off-white lyophilized powder |
| Purity specification (HPLC) | ≥ 99.0% |
| On every batch COA | RP-HPLC purity · ESI-MS identity · Bacterial endotoxin · Fill amount (content per vial) |
| On request | LC-MS/MS sequence confirmation · Net peptide content · Water content (Karl Fischer) · Counter-ion content (e.g. acetate, TFA) · Microbial limits |
| Storage | -20°C lyophilized; 2–8°C reconstituted, protect from light |
| Strengths per vial | 2 mg · 5 mg · 10 mg · 20 mg |
| Pack | 10 vials per kit |
| MOQ | On request |
| Lead time | 7–14 days |
| Use | Research use only — not for human or veterinary use |
Identity data from the Lyochem product catalogue, checked against PubChem and registry records. The batch COA of your lot is the record for that lot's results. How to verify a COA
Lot documentation
Values belong to the lot. Ask for the COA of the offered lot before you order.
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Third-party reportBPC-157 5 mg
HPLC purity · MS identity
Third-party laboratory, Tianjin, China
Full, clear copy from sales
Third-party reportBPC-157 10 mg
HPLC purity · MS identity
Third-party laboratory, Tianjin, China
Full, clear copy from sales
Independent test fails? Full refund. How it works
Research documentation
Discuss BPC-157 identity, purity, and documentation requirements with sales before selecting a lot for research qualification. Confirm the evidence needed for sequence verification, method development, stability testing, or reference-material comparison. This material is for research use only.
Overview
BPC-157 is a 15-residue partial sequence (GEPPPGKPADDAGLV) of a protective protein first characterized in human gastric juice, and its proline-dense composition confers marked resistance to gastric and serum proteases. That stability underlies its use across tissue-repair models spanning tendon and ligament healing, gastrointestinal mucosal protection, endothelial and vascular repair, and post-injury bone metabolism. The peptide has drawn regulatory attention (notably the July 2026 FDA Pharmacy Compounding Advisory Committee agenda), but for laboratory buyers the operative questions remain chemical purity, confirmed sequence, and lyophilate stability rather than any compounding pathway. Lyochem supplies BPC-157 acetate as a lyophilized reference standard to a ≥99.0% HPLC purity specification. The short chain synthesizes reliably by SPPS, yet closely eluting truncation impurities demand rigorous purification, so every released lot comes with its batch COA recording peak-integrated RP-HPLC and ESI-MS agreeing within 0.5 Da of the theoretical 1419.55 g/mol. LC-MS/MS sequence confirmation can be included when required by the buyer’s written analytical scope; ask sales to confirm method, timing, and cost before quotation. BPC-157 also anchors the Wolverine Blend (with TB-500) and GLOW Blend formulations; although BPC-157 (proline-rich gastric-protective peptide) and TB-500 (actin-binding 43-mer) are mechanistically unrelated, the Wolverine Blend SKU provides their canonical 1:1 co-lyophilate, with full composition stated on the COA.
Applications & buyer fit
Repair peptides — BPC-157, TB-500, PEG-MGF — ship primarily to research laboratories. The applicable batch COA records the tests actually completed. Tandem-MS sequence evidence is an additional agreed scope when the buyer's written procedure requires it, not a blanket requirement to repeat release testing.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Academic Laboratories
Universities, medical schools, and government research institutes qualifying a reference standard for a method-development or in vivo workflow.
Every lot has its own batch-specific CoA — RP-HPLC purity, ESI-MS identity, bacterial endotoxin and fill amount, plus any analytical scope agreed at quote stage — tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Other formats

BPC-157 is also kept as a solution in nasal spray bottles.
| Contents | 2 mg, 5 mg, 10 mg |
|---|---|
| Fill volume | 10 mL or 20 mL |
| Minimum | 10 bottles per content and volume |
| Stock | Held in the United States, shipped within the US |

Capsule format
BPC-157 is also held as capsules in US stock and shipped within the US.
| Per capsule | Strengths in stock on enquiry |
|---|---|
| Shipped from | US stock |
| Use | Research use only |
Regulatory note
Lyochem supplies BPC-157 strictly for Research Use Only; buyers are responsible for verifying ingredient eligibility in their destination market.
Selected literature
Frequently asked questions
BPC-157 is a 15-residue peptide, and its proline-rich stretch does not change how it is characterized analytically. RP-HPLC with UV detection reports chemical purity and resolves the target from deletion or truncation impurities, ESI-MS confirms the intact mass, and LC-MS/MS sequence verification reads the b- and y-ion ladder to confirm the residue order. Sequence-level confirmation matters because mass alone can be ambiguous among short peptides, so requesting explicit sequence data on the batch COA is the reliable way to establish that the supplied material is BPC-157 and not a near-mass variant.
BPC-157 is commonly supplied as the acetate salt, and the salt form is part of accurate characterization because it affects both RP-HPLC retention and the mass balance of the vial. The acetate form elutes slightly earlier than free base under typical reverse-phase conditions, so retention should be interpreted against the stated salt. For dosing, the COA should report net peptide content after subtracting counter-ion and Karl Fischer water from the fill weight, since biological activity tracks actual peptide mass. Specifying free base versus acetate at quote stage ensures the reference data and the delivered form match your downstream work.
Yes: 2 mg, 5 mg, 10 mg, in 10 mL or 20 mL bottles, minimum 10 bottles per content and volume. This format is held in the United States and shipped within the US; contact sales for availability and a quotation.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
43-mer
Full-length Thymosin β4 (43 residues)
Also in nasal spray
Co-characterized tissue-repair pairing (BPC-157 + TB-500)